Dr. Steven Idell, VP for research at UT Health Center, is internationally known for his research into pulmonary fibrosis
Tuesday, May 16, 2006
Steven Idell, MD, Ph.D., has an international reputation because of his research into the causes and treatment of pulmonary fibrosis, or lung scarring. He is vice president for research at The University of Texas Health Science Center at Tyler.
Dr. Idell is director of a five-year, almost $7.8 million grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, to study how to protect the lungs from scarring. The grant, which began in September 2005, is the largest NIH grant UTHSCT has received so far.
Dr. Idell and his team of scientists are investigating how the cells lining the lungs and airways contribute to lung scarring. He and his team then will test ways to prevent it. Symptoms of lung scarring include shortness of breath, chronic cough, and fatigue. According to the Pulmonary Fibrosis Foundation, about 40,000 Americans die from lung scarring, or pulmonary fibrosis, each year.
Recently appointed to an NIH panel that will decide how resources in the Blood Institute of the National Heart, Lung, and Blood Institute will be allocated, Dr. Idell also is on NIH’s Idiopathic Pulmonary Fibrosis Network protocol review panel. This oversight group will determine how clinical trials involving people with idiopathic pulmonary fibrosis – lung scarring of unknown origin – will be conducted at participating medical centers throughout the United States.
Dr. Idell is a fellow of the American College of Chest Physicians and the American College of Physicians and a past president of the Texas Thoracic Society. He is associate editor for Clinical Pulmonary Medicine and serves on the editorial boards of the American Journal of Respiratory and Critical Care Medicine, the American Journal of Physiology: Lung Cellular and Molecular Physiology, and Emergency Medicine. Dr. Idell also is on the advisory board for the International Pleural Disease Newsletter. He is board certified in internal medicine, pulmonary disease, and critical care medicine.
As vice president for research, Dr. Idell oversees laboratory and clinical operations related to basic and clinical research at UT Health Science Center. This includes the Center for Pulmonary and Infectious Disease Control, which supports research into infectious diseases such as tuberculosis.
Dr. Idell received his medical degree from Temple University School of Medicine in Philadelphia in 1977, followed by a doctoral degree in physiology in 1987 from the same institution. He specialized in research into thrombosis, the process by which blood clots, as well as clot destruction and how these processes relate to the pathogenesis of lung injury and repair.